Format

Send to

Choose Destination
Account Res. 2008 Jul-Sep;15(3):152-67. doi: 10.1080/08989620802194384.

Industry-sponsored ghostwriting in clinical trial reporting: a case study.

Author information

1
Department of Philosophy, California State University, Northridge, California 91330, USA. leemon.mchenry@csun.edu

Abstract

In this case study from litigation, we show how ghostwriting of clinical trial results can contribute to the manipulation of data to favor the study medication. Study 329 for paroxetine pediatric use was negative for efficacy and positive for harm. Yet the ghostwritten publication from this study concluded that paroxetine provided evidence of efficacy and safety and continues to be influential. Despite the role of named authors in revisions of the manuscript, the sponsor company remained in control of the message.

PMID:
18792536
DOI:
10.1080/08989620802194384
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center